← Back to Clinical Trials
Recruiting NCT07553962

NCT07553962 Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07553962
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Smoking (Tobacco) Addiction
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2025-03-20
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2025-03-20 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Smoking is the leading preventable cause of death in the United States, and quitting is especially difficult for couples who both smoke. When both partners smoke, they are less likely to quit successfully and more likely to relapse compared to people whose partner does not smoke. Research suggests that the way romantic partners interact and support each other during a quit attempt can make a real difference - but researchers do not yet know enough about what kinds of support actually help. This study examines a concept called "communal coping," which refers to when partners treat a shared health challenge - like quitting smoking - as something they are facing together as a team rather than as separate individuals. Researchers believe that couples who approach quitting this way may have better outcomes. To study this, researchers will ask both members of dual-smoking couples to complete brief daily surveys over two weeks while making a quit attempt. These surveys will track how partners support (or discourage) each other's quitting efforts on a day-to-day basis, along with cigarette use, cravings, and stress. This will help researchers understand which relationship patterns are most helpful for quitting, and identify specific targets for future couples-based smoking cessation programs.

Eligibility Criteria

Inclusion Criteria: * Are over the age of 18 * Smoke cigarettes on a daily basis * Smoke at least 5 cigarettes per day on average * Are in a committed relationship with an individual who smokes at least 5 cigarettes per day on average and is willing to participate in the study * Are willing to make a smoking cessation attempt at the time of enrollment into the study (applies to only one partner).

Contact & Investigator

Central Contact

Slaton Z Freeman, M.A.

✉ zane.freeman@ucdenver.edu

📞 512-755-1814

Frequently Asked Questions

Who can join the NCT07553962 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking (Tobacco) Addiction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07553962 currently recruiting?

Yes, NCT07553962 is actively recruiting participants. Contact the research team at zane.freeman@ucdenver.edu for enrollment information.

Where is the NCT07553962 trial being conducted?

This trial is being conducted at Denver, United States.

Who is sponsoring the NCT07553962 clinical trial?

NCT07553962 is sponsored by University of Colorado, Denver. The trial plans to enroll 250 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology